GT
ATHE

Greenleaf Trust’s Alterity Therapeutics ATHE Stock Holding History

Greenleaf Trust’s Portfolio ATHE Stock Details ATHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$333K Buy
62,000
+30,000
+94% +$131K ﹤0.01% 655
2026
Q1 		$111K Hold
32,000
– – ﹤0.01% 793
2025
Q4 		$98.6K Hold
32,000
– – ﹤0.01% 810
2025
Q3 		$120K Buy
32,000
+15,000
+88% +$72.4K ﹤0.01% 797
2025
Q2 		$69.5K Buy
+17,000
New +$66.7K ﹤0.01% 790

Other funds holding ATHE

TLCM
Twin Lakes Capital Management Redwood Shores, California $262M AUM 60.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
PCA
Providence Capital Advisors Charlotte, North Carolina $660M AUM 17.81% 1-Year Est. Return

Greenleaf Trust's ATHE Position: Q2 2026 in Review

Greenleaf Trust increased its Alterity Therapeutics (ATHE) stake by 94% in Q2 2026, buying an estimated $131K and bringing the position to 62,000 shares worth $333K. The position accounts for ﹤0.01% of the portfolio, ranked #655.

Greenleaf Trust first reported a position in ATHE in Q2 2025 and has held it in 5 quarters since. 22 funds tracked by Wall St. Rank hold ATHE as of Q2 2026.

  • Greenleaf Trust held 62,000 shares of Alterity Therapeutics worth $333K as of Q2 2026.
  • Greenleaf Trust bought 30,000 Alterity Therapeutics shares in Q2 2026, an estimated $131K.
  • Alterity Therapeutics made up ﹤0.01% of Greenleaf Trust's portfolio in Q2 2026, its #655 holding.
  • Greenleaf Trust first reported a position in Alterity Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 22 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.